Impact of Dexmedetomidine on Pediatric Agitation in the Postanesthesia Care Unit

Area of Science:

• Anesthesiology
• Pediatric Surgery
• Pharmacology

Background:

• Postoperative agitation is a common concern in pediatric patients following tonsillectomy.
• Managing emergence agitation and pain is crucial for a positive recovery experience.

Purpose of the Study:

• To evaluate the efficacy of dexmedetomidine (DEX) in mitigating agitation in the postanesthesia care unit (PACU) for pediatric tonsillectomy patients.
• To assess the impact of DEX on pain scores, nausea, vomiting, and the need for rescue analgesia.

Main Methods:

• A randomized controlled trial involving 82 pediatric patients undergoing elective tonsillectomy.
• Patients were divided into two groups: one receiving dexmedetomidine (DEX) infusion and a control group.
• Data collected included operation time, extubation time, PACU stay, pain scores, agitation scores, nausea/vomiting incidence, and fentanyl requirements.

Main Results:

• The DEX group exhibited significantly lower maximum pain and emergence agitation scores in the PACU compared to the control group (P < .01).
• Incidence of severe agitation and need for rescue fentanyl were significantly reduced in the DEX group (P < .01).
• Nausea and vomiting were also significantly less frequent in the DEX group (P < .05).

Conclusions:

• Low-dose dexmedetomidine is effective in reducing delirium and agitation during the PACU phase after pediatric tonsillectomy.
• The study found no significant adverse hemodynamic events associated with DEX administration in this patient population.